Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
about
Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injuryCopper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.Do cytokines have any role in Wilson's disease?Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancerCopper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivoWilson's disease: clinical, genetic and pharmacological findings.Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapyCurrent Drug Managements of Wilson's Disease: From West to East.Current and emerging drugs for idiopathic pulmonary fibrosis.Synthetic lethal targeting of superoxide dismutase 1 selectively kills RAD54B-deficient colorectal cancer cells.Endothelial Antioxidant-1: a Key Mediator of Copper-dependent Wound Healing in vivo.Wilson's disease: update on integrated Chinese and Western medicine.Lysyl oxidase isoforms in gastric cancer.Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro.Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate.Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders.Epidemiology, diagnosis, and treatment of Wilson's disease.Copper chaperone antioxidant-1, Atox-1, is involved in the induction of SOD3 in THP-1 cells.Advances in Treatment of Wilson Disease.Copper metabolism and inherited copper transport disorders: molecular mechanisms, screening, and treatment
P2860
Q24812664-13E8B8A0-729A-4EA4-B03E-B7FDEC96094FQ28580309-1FC7A9E5-4844-47AB-8EBF-4763C4B8D968Q30666915-D1E37177-02A6-4509-B59E-09B28787FD68Q33381318-23B84BD6-3F6C-46C3-B78C-DCED72F80C84Q34028117-6274D6BB-9573-49B8-AFCF-55E690D5F798Q34291420-E41BD67F-391E-44E8-A60C-47DC5FC6E0BFQ35314903-2814CCB8-7DE4-41E8-8B4F-ACE49D83619EQ36033407-0F9C36F7-9CED-48B4-96B7-2259D6CADBD3Q36440438-5F631819-42C1-4D93-B431-BAEFB3F209E5Q36925896-F4548213-9514-4907-B223-344E9DE2AE0BQ36989934-D4B0808C-4B05-4803-BBC7-AECD157852EBQ37269800-AFF50188-ACD9-4725-886C-AA7F85417554Q37281970-625D5463-DD96-433B-8262-53F4BB82209DQ38011659-A8800803-9AFC-48BC-A1CD-D04E66BB7A84Q38937873-9AE3A170-307D-47FF-AC8C-88C0522FE700Q39063509-1A4AD718-07A4-4D38-A4AA-25F938739467Q41520294-C3CE8ABF-3138-4669-A5C8-70A5EF1C6A45Q42368453-E565108A-F283-4187-B385-29C61CF4DAFAQ47096308-497C5847-2451-4F51-B780-FA6C7C53F602Q47371795-528224E8-F01B-4A32-AEA9-EBF592DED57AQ55400494-290A88D3-AC52-4A9B-B450-B4B66DDD94C7Q56552176-48ABDC10-C38F-4408-BDDF-AEAF4E31A2A9
P2860
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@ast
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@en
type
label
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@ast
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@en
prefLabel
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@ast
Tetrathiomolybdate anticopper ...... is, fibrosis and inflammation.
@en
P2860
P1476
Tetrathiomolybdate anticopper ...... sis, fibrosis and inflammation
@en
P2093
G J Brewer
P2860
P356
10.1111/J.1582-4934.2003.TB00198.X
P577
2003-01-01T00:00:00Z